Subsense Adds $10M Funding for Non-Surgical Brain-Computer Interface Development
Summary
Subsense has added $10 million in funding to support its brain-computer interface research and development. The company is developing a non-surgical BCI approach using nasal nanoparticles for bidirectional brain-computer interfacing, combining engineered nanoparticles, hardware, and signal-processing software to non-invasively read and modulate brain activity. The additional funding brings the company's total raised to approximately $27 million and will accelerate development of this novel BCI modality.
Why it matters
Subsense's nanoparticle-based approach represents one of the more unconventional approaches to non-invasive BCI, potentially offering a pathway to high-fidelity brain interfacing without surgery or wearable devices. If the technology works as hypothesized, it could circumvent many of the signal quality limitations that plague external BCI approaches. The $10M top-up demonstrates continued investor interest in funding diverse technical approaches to the BCI challenge beyond more established electrode-based or ultrasound methods.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial